Rx Medicare

URL Pharma, Inc., announced data from a pivotal Phase III study demonstrating that Colcrys(TM) (colchicine, USP), a low-dose colchicine, reduced the pain of gout flares within a 24-hour period as effectively as high-dose colchicine with a side effect profile statistically indistinguishable from placebo. These data and two other Colcrys studies were presented this week at the 2009 American College of Rheumatology (ACR) Annual Scientific Meeting in Philadelphia.

Read More…

Related Posts

• New Data From Caldolor(R) Study In Burn Patients To Be Presented At 42nd Annual Meeting Of The American Burn Association
• Acute Study Demonstrates Safety Of Vertos Medical’s Mild(R) Procedure; Findings Appear In Pain Physician Journal
• Newly Published Clinical Data Shows Caldolor(R) (Ibuprofen) Injection Reduces Opioid Use While Improving Pain Relief In Post-Operative Patients
• Data Suggest Sodium Oxybate Significantly Improves Pain And The Core Symptoms Of Fibromyalgia
• Lyrica Significantly Reduced Pain And Improved Other Symptoms Of Post-Traumatic Peripheral Nerve Pain, New Data Show
• New Opinion Data Revealed Alongside British Pain Society Annual Scientific Meeting Shows Importance Of Managing Side Effects When Treating Pain
• Multi-Center Data In A Large Series Of Patients Show Vertebroplasty Provides Dramatic And Lasting Pain Relief For Vertebral Compression Fractures
• Cymbalta(R) Significantly Reduced Chronic Low Back Pain In New Study
• New, Targeted Pain Medicine Delivery Systems May Reduce Costs Long Term; Cost To Treat Pain Varies Significantly By Chronic Pain Condition
• SOMA 250 MG Shown To Significantly Improve Functionality And Reduce Disability In Patients With Low Back Pain In Three Days
• FDA Approves Morphine Sulfate Oral Solution For Relief Of Acute And Chronic Pain
• Slow Breathing Reduces Pain
• QRxPharma Initiates Pivotal Phase 3 Study Of MoxDuo(TM)IR For Moderate To Severe Acute Pain
• CNSBio Inc. To Present Latest Clinical Trial Data For CNSB015 At Neuropathic Pain Conference In San Francisco
• AcelRx Announces Successful Completion Of End-of-Phase 2 Meeting On ARX-01, Sufentanil NanoTab PCA System For Post-Operative Pain Management

Tags: acute, colchicine, colcrystm, data, demonstrates, flare, gout, hours, meeting, pain, presented, reduces, significantly, within

This entry was posted on Tuesday, October 20th, 2009 at 8:10 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.